Conclusive evidence for defective neurodevelopment in schizophrenia is lacking. Two DNA methylation studies now draw a link between fetal brain epigenomes, epigenetic alterations in the adult diseased brain and genetic risk for the disease.
This is a preview of subscription content, log in via an institution to check access.
Katie Vicari/Nature Publishing Group
References
Jaffe, A.E. et al. Nat. Neurosci. 19, 40–47 (2016).
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Nature 511, 421–427 (2014).
Hannon, E. et al. Nat. Neurosci. 19, 48–54 (2016).
Roussos, P. et al. Cell Reports 9, 1417–1429 (2014).
De Jager, P.L. et al. Nat. Neurosci. 17, 1156–1163 (2014).
Huynh, J.L. et al. Nat. Neurosci. 17, 121–130 (2014).
Iwamoto, K. et al. Genome Res. 21, 688–696 (2011).
Lister, R. et al. Science 341, 1237905 (2013).
Cheung, I. et al. Proc. Natl. Acad. Sci. USA 107, 8824–8829 (2010).
Mo, A. et al. Neuron 86, 1369–1384 (2015).
Maze, I. et al. Neuron 87, 77–94 (2015).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Sharp, A., Akbarian, S. Back to the past in schizophrenia genomics. Nat Neurosci 19, 1–2 (2016). https://doi.org/10.1038/nn.4203
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.4203
- Springer Nature America, Inc.